|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Sep 20, 2018 |
Title |
Bulk RNA-seq U2OS cells treated with small molecules |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
We report the transcriptional changes associated with treatment of U2OS osteosarcoma cell line with DMSO, AML108, AMN107, BGW675, JAA804, LEE837 and LHD510.
|
|
|
Overall design |
U2OS cells were treated with 100nM, 1000nM and 10000nM of DMSO, AML108, AMN107, BGW675, JAA804, LEE837 and LHD510 for 12 hrs and subjected to RNA-seq.
|
|
|
Contributor(s) |
Kaykas A, Altshuler R |
Citation(s) |
30333485 |
|
Submission date |
Sep 19, 2018 |
Last update date |
Mar 21, 2019 |
Contact name |
Ajamete Kaykas |
E-mail(s) |
ajamete.kaykas@novartis.com
|
Organization name |
Novartis
|
Street address |
22 Windsor St
|
City |
Cambridge |
ZIP/Postal code |
02139 |
Country |
USA |
|
|
Platforms (1) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (72)
|
|
Relations |
BioProject |
PRJNA492171 |
SRA |
SRP162188 |
Supplementary file |
Size |
Download |
File type/resource |
GSE120222_RAW.tar |
99.4 Mb |
(http)(custom) |
TAR (of TXT) |
SRA Run Selector |
Raw data are available in SRA |
Processed data provided as supplementary file |
|
|
|
|
|